BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances
Atossa Genetics, Inc. (ATOS) Announces Commercial Partner for Laboratory Services Offered By The National Reference Laboratory For Breast Health, Inc. 8/28/2014
United States Department Of Commerce Partners With Virocyt To Expand Asian Markets 8/28/2014
Mafraq Hospital Improves Diabetic Care After University Collaboration 8/28/2014
Dow Microbial Control Forges Commercial Agreement With Xgenex For U.S. Sales Of Dow AOS Certified Technology 8/28/2014
BioTime (BTX) To Collaborate With The University of Wisconsin And Louvain University In Test Of Hystem®-Based Hydrogel For Vocal Fold Scarring 8/28/2014
Formal Transfer Of Global Rights For Tozadenant To BioTie Therapies Corp. Concluded 8/28/2014
Innovus Pharma Signs Exclusive Marketing And Distribution Agreement With Danalife Aps To Market And Distribute Zestra® For Alternative Markets 8/28/2014
Drug Giants Merck & Co., Inc. (MRK) And Pfizer Inc. (PFE) Forge Cancer Pact 8/27/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
LabSmith, Inc. Products Now Distributed In South Korea By Revodix, Inc. 8/27/2014
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co., Inc. (MRK) To Test Immune Therapies Against Prostate Cancer 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
ViveBio And Laboratory Procurement Services Sign Agreement For Distribution Of The ViveST Line Of Products 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial 8/26/2014
Novozymes A/S (NVZMY) And Monsanto Company (MON) Showcase New Ag Innovations Expected To Increase Sustainability On The Farm 8/26/2014
iBio, Inc. (IBIO) Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8/26/2014
AB SCIEX And Dalton Pharma Services Collaborate To Advance Antibody-Drug Conjugate Analysis 8/26/2014
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014
MRC Technology Negotiates License With Bio-Techne For MRC’s GOPAL Protein Synthesis Technology 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Eurolab Especialidades Medicinales For Brinavess™ In Argentina 8/25/2014
Tauriga Sciences Inc. (TAUG) Executes Investment Banking Agreement With Tokyo, Japan Based Dragoon Capital Inc. 8/25/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development 8/22/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces New Exclusive Global Manufacturing And Supply Agreement For Lubiprostone 8/22/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
Angiocrine Bioscience Licenses New Stem Cell Technology From Weill Cornell Medical College 8/21/2014
New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein, PhD To Advance Pulmonary Fibrosis Research 8/21/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Nature Publishing Group & Journal Of Commercial Biotechnology 8/21/2014
Vensun Pharmaceuticals Enters Into Manufacturing, Supply and Distribution Agreement With ScieGen Pharmaceuticals, Inc. 8/21/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
Sarepta Therapeutics (SRPT) Enters Into Partnership With Flagship Biosciences LLC To Digitally Automate The Measurement Of Dystrophin, A Key Therapeutic Efficacy Marker For Muscular Dystrophy 8/21/2014
Gallus Biopharmaceuticals, LLC Enters Agreement With Progenics Pharmaceuticals, Inc. (PGNX) For Manufacture Of Anti-PSMA Monoclonal Antibody 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Igenbio, Inc. And Genome Compiler Corp. Enter Into A Collaborative Agreement To Offer Synthetic Biology Solutions 8/20/2014
Global Institute Of Forensic Research Contracts With The Council Of State Governments To Provide Executive Bulletin Service 8/20/2014
Bristol-Myers Squibb Company (BMY) And Celgene (CELG) Enter Clinical Collaboration Agreement To Evaluate Immunotherapy And Chemotherapy Combination Regimen 8/20/2014
Crohn's and Colitis Foundation of America Release: Expanding IBD Research Through Collaboration 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Mount Tam Biotechnologies Awarded Worldwide Exclusive License For Research Assets From the Buck Institute -- Advancing Promising Medical Compounds For The Treatment of Lupus Towards The FDA Drug Approval Process 8/19/2014
Roche (RHHBY) And Garvan Institute of Medical Research Partner To Develop Genomics Technologies For Targeted Epigenomic Analysis 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. (CYTX) For Burn Treatment, Deal Is Worth Up To $20.4 Million 8/19/2014
CAPSUGEL And Cardax Pharmaceuticals Inc. To Collaborate On Development Of Proprietary Astaxanthin Products 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
Abbott Laboratories (ABT) Strikes $20 Million Pentagon Deal For Brain Injury Device 8/18/2014
Pharpoint Research Wins Project Award From Otologic Pharmaceuticals 8/18/2014
Expression Therapeutics Selects Advanced BioScience Laboratories, Inc. To Support Cell Line Development For Hemophilia A Factor VIII Infusion Therapy 8/18/2014
Immune Targeting Systems (ITS) Ltd. And WCCT Global Announce A New Influenza A H1N1 Virus To Support The Experimental Human Viral Challenge Model 8/18/2014
MMS Holdings, Inc. And Oncology Trials Insights Form Strategic Partnership To Deliver Comprehensive Oncology Support Services 8/18/2014
HUYA Bioscience International Announces Partnership With Changzhou Center For Biotech Development 8/18/2014
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd. 8/18/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $2 Million From The Advancement Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 8/15/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
Innovus Pharma And Consortia Health Initiate A Nationwide Marketing And Sales Campaign To U.S. Gynecologists For Zestra®, Clinically Proven For The Enhancement Of Female Arousal Desire And Satisfaction 8/15/2014
ImmuDyne, Inc. (IMMD) Announces Launch Of Clinical Study 8/15/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Ligand Pharmaceuticals Inc. (LGND) Signs Multi-Program Captisol® License Agreement With Avion Pharmaceuticals 8/14/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
23andMe, Inc., Pfizer Inc. (PFE) Strike Pact To Research The Genetics Of Inflammatory Bowel Disease 8/12/2014
ITEN And Biogenerator Work Together At Intersection Of IT And Bioscience Startups 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Feist-Weiller Cancer Center Partners With Caris Life Sciences To Establish A Clinical Molecular Profiling Program 8/12/2014
FORMA Therapeutics, Inc. And Paradigm Announce Molecular Profiling Collaboration For Drug Candidates 8/12/2014
Fred's And Cardinal Health, Inc. (CAH) Announce Primary Supply Agreement 8/12/2014
Marinus Pharmaceuticals (MRNS) Enters Into Use Agreement With CyDex Pharmaceuticals For Use Of Captisol® For Ganaxolone IV 8/12/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects 8/11/2014
Human Longevity Inc. And Celgene Cellular Therapeutics Sign License Agreement To Develop And Commercialize Placental Stem Cell Population, PSC-100 For Multiple Therapeutic Applications 8/11/2014
Radient Technologies Inc. Awarded Contract By Fortune 500 Consumer Staples Company 8/11/2014
Cryoprinting Red Blood Cells: Akron Biotechnology, LLC And Stanford University Collaborative Study 8/11/2014
ALR Technologies Inc. To Conduct Clinical Trial With Premier Hospital Of Chilean Health Ministry In Santiago 8/11/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
Sigma-Tau Pharmaceuticals Signs Exclusive Agreement With Crosscare Limited For U.S. Marketing And Distribution License Of Colief® Infant Drops For The Treatment Of Colic-Associated Crying 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
U.S. Government Exercises Contract Options Valued At $18.9 Million For Emergent BioSolutions (EBS)' Vaccinia Immune Globulin Intravenous Program 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014
Daiichi Sankyo, Inc. (4568.t) Wagers Up To $650 Million On Charleston Laboratories, Inc.'s Pain And Opioid-Induced Nausea And Vomiting Drug 8/7/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014
Terumo BCT Announces Collaboration To Evaluate Clinical Cell Production Using Quantum System 8/7/2014
Idera Pharmaceuticals, Inc. (IDRA) And The Myositis Association Join Forces To Advance The Clinical Development Of A Novel TLR Antagonist, IMO-8400, For The Treatment Of Myositis 8/7/2014
Vivex Biomedical And Akron Biotech: Collaborative Venture In Regenerative Medicine 8/7/2014
Leica Biosystems And Bristol-Myers Squibb Company (BMY) Enter Into A Development And Commercialization Collaboration For Companion Diagnostics That Support Targeted Therapies 8/7/2014
Blacktrace Holdings Ltd. To In-License PerkinElmer, Inc. (PKI)Technology 8/7/2014
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014
Pfizer Inc. (PFE), Roche (RHHBY) Join Consortium In Effort To Up Success Of Late-Phase Clinical Work 8/6/2014
Yabao Pharmaceuticals And Changzhou Le Sun Pharmaceuticals Ltd. Enter An Innovative Partnership To Develop Early-Stage Oncology Compound 8/6/2014
Biopredic International And Triangle Research Labs Announce The Distribution Of No-Spin Cryopreserved Heparg™ Cells By TRL In The United States 8/6/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014
Meridian Bioscience, Inc. (VIVO) And The University Of Tennessee Research Foundation Enter Into A License Agreement For Electrokinetic Sensor Technology 8/6/2014
Aegis Therapeutics, LLC Release: First Non-Injectable GLP-1 Analog For Type-2 Diabetes 8/6/2014
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014
Catylix, Inc. And Aspira Scientific Announce Cooperation To Produce And Distribute Hartwig Trifluoromethylator® Reagent 8/6/2014
Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs 8/6/2014
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014
NewLink Genetics, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From The Defense Threat Reduction Agency For Testing And Evaluation Of Ebola Virus Vaccine 8/5/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercial Agreement For Iclusig (Ponatinib) In Israel 8/5/2014
Ignyta (RXDX) And Nerviano Medical Sciences (NervianoMS) Announce License Agreement For Two First-in-Class Kinase Inhibitors 8/5/2014
Molecular Targeting Technologies, Inc. And National Health Research Institutes Have Joined Forces In Developing Novel Cancer Therapeutics 8/5/2014
CritiTech And European Medical Contract Manufacturing Announce Collaboration To Develop API-Coated Tissue Grafts 8/5/2014
Arena Solutions And SiliconExpert Partner To Reduce Supply Chain Risk 8/5/2014
Geron Corporation (GERN) To Assume Sponsorship Of Myelofibrosis IST And IND 8/5/2014
PatientsLikeMe And Actelion Ltd. (ALIOF.PK) To Develop New Patient-Reported Measure For Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL) 8/5/2014
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property For The Treatment Of Epilepsy And Other Seizure-Related Disorders With Triheptanoin 8/5/2014
Cesca Therapeutics And Fortis Healthcare Announce Master Collaboration Agreement 8/5/2014
ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group 8/5/2014
Dyadic International, Inc. And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology 8/5/2014
Regulus Therapeutics, Inc. Enters Into New Collaboration Agreement With Biogen Idec, Inc. (California) (BIIB) To Identify Microrna Biomarkers In Multiple Sclerosis 8/5/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Heritage Pharmaceuticals Signs Exclusive Development Supply & Distribution Agreement With Dexcel Ltd. 8/5/2014
Kapa Biosystems Strengthens Investment Across Asia Pacific Region By Extending Exclusive Japanese Distribution Agreement With NIPPON Genetics 8/4/2014
KannaLife Sciences, Inc. Signs New License Agreement With National Institutes of Health (NIH) For Treatment Of Chronic Traumatic Encephalopathy 8/4/2014
Kadimastem To Collaborate With Merck Serono To Advance Combined Efforts In Neurodegenerative Disease Area 8/4/2014
Vernalis PLC (VNLPY.PK) And Servier Achieve Two Research Milestones In Their Oncology Collaborations 8/4/2014
Medivir AB (MVRBF) Licenses Respiratory Syncytial Virus Drug Program From Boehringer Ingelheim Corporation 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
BioGasol Establishes Licensed Carbofrac® Reactor Manufacture By Sweetwater Energy 8/4/2014
California Institute of Technology Release: Prominent U.S. Research Institutions Announce Collaboration Toward Sharing And Standardizing Neuroscience Data 8/4/2014
AmorChem l.p., Université Laval And CHU De Québec Collaborate On The Development Of A Treatment For Friedreich’s Ataxia 8/4/2014
FEI Company Reports New Advances In Neuroscience In Collaboration With National Institutes of Health (NIH) 8/4/2014
Facebook And Reckitt Benckiser Pharmaceuticals Inc. Partner On Innovative Global Approach To Effectively Reach Consumers In Their Digital Lives 8/4/2014
Organogenesis Inc. Awarded A 5-Year Federal Supply Schedule Agreement With The Department Of Veteran Affairs 8/4/2014
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014
AIBioTech Teams With Leidos For Air Force Contract 7/31/2014
Columbia Laboratories, Inc. (CBRX)'s Subsidiary, Molecular Profiles, Strikes Alliance With XenoGesis Ltd. 7/31/2014
Rogne Bioscience, Inc. Release: Oxford Licenses Anti-Inflammatory Peptides To San Francisco Bay Area Start-Up 7/31/2014
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/31/2014
Invitae And Nanopharmacia Announce Partnership To Make Reliable, Fast And Affordable Hereditary Cancer Genetic Testing Broadly Available In Mexico 7/31/2014
Sirona Biochem Announces Successful Synthesis Of Anti-Inflammatory Compound For Bloom Burton & Co. Joint Venture 7/31/2014
Catylix, Inc. And Aspira Scientific Announce Joint Venture To Commercialize New Fluorination Technologies 7/31/2014
ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research 7/31/2014
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials 7/30/2014
Leidos Awarded $44 Million Contract By The Centers for Disease Control and Prevention (CDC) 7/30/2014
PCI Announces Definitive Agreement To Acquire Penn Pharma 7/30/2014
Proteostasis Therapeutics, Inc. Announces Achievement Of Preclinical Milestone In Neurodegenerative Diseases Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) 7/30/2014
Florida Institute Funds Miami-based RxMP Therapeutics, LLC 7/30/2014
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/30/2014
Durata Therapeutics, Inc.  (DRTX) Enters Into An Exclusive License And Supply Agreement With Angelini To Commercialize Dalbavancin In Certain European Territories, Russia And Turkey 7/30/2014
Lion Biotechnologies, Inc. Enters Clinical Trial Grant Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/30/2014
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Actimab-A Clinical Trial 7/30/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaboration With Life Sciences Market Intelligence Firm Evaluate Ltd. 7/30/2014
Theraclone Sciences, Inc. Announces Exclusive Agreement With Gilead Sciences, Inc. (GILD) For Broadly Neutralizing HIV Antibodies 7/30/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration 7/30/2014
Kaiser Permanente, Johns Hopkins Medicine Announce Enhanced Strategic Collaboration 7/30/2014
Sanofi (France) (SAN.PA) Abandons Antibiotics Deal With South San Francisco's KaloBios Pharmaceuticals, Inc. (KBIO) 7/29/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests 7/29/2014
Rosetta Genomics Ltd. (ROSG) Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's Nancy And Stephen Grand Israel National Center For Personalized Medicine 7/29/2014
Intrexon Corporation Enters Into Technology Collaboration To Advance Animal Health Applications 7/29/2014
Advaxis, Inc. And The University of Pennsylvania Restructure Their Exclusive License Agreement 7/29/2014
Roche (RHHBY) And AmorChem l.p. Announce Alliance Focused On Myotonic Muscular Dystrophy 1 7/29/2014
SDK And BIA Separations Expanding Their Co-operation 7/29/2014
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014
Flexion Therapeutics (FLXN) And Southwest Research Institute (Swri®) Sign Worldwide Exclusive License For Proprietary Microsphere 7/29/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders 7/28/2014
Targeted Medical Pharma Agrees To Sponsor A Clinical Trial Conducted By The United States Army And Henry M. Jackson Foundation For The Advancement Of Military Medicine 7/28/2014
CANbridge Life Sciences And EUSA Pharma Form Agreement To Commericalize Caphosol® In China 7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London 7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014
MYOS (MYOS) Extends Manufacturing And Supply Agreement For Fortetropin 7/25/2014
Lion Biotechnologies, Inc. Announces Exclusive License Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/25/2014
Parnell Pharmaceuticals Holdings Acquires License For Intellectual Property And Rights To Develop Compounds For Bone And Dermal Regeneration 7/25/2014
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials 7/24/2014
Cubist Pharmaceuticals, Inc. (CBST) Strikes Agreement With Competitor To Delay Generic Cubicin 7/24/2014
Taconic Announces New Agreement To Distribute Next Generation NOG Mouse Models 7/24/2014
Agilent Technologies Inc. (A) Signs Co-Marketing Agreement With MRM Proteomics To Advance Quantitative Proteomics Solutions 7/24/2014
LSI Medience Corporation And Kineticos Sign Agreement Related To The Presepsin Biomarker In Sepsis Management And Treatment 7/24/2014
Evogene Ltd. (EVGN) Announces Amendment To Bayer Wheat Agreement To Focus On Discovery Of Novel Genomic Promoters 7/24/2014
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan 7/24/2014
Cipher Pharmaceuticals (DND.TO) And Ranbaxy Laboratories (RANBAXY.BO) Announce Distribution Agreement For Isotretinoin Product In Brazil 7/24/2014
TransCelerate BioPharma Selects Cognizant (CTSH) To Develop A Clinical Trials Collaboration Platform 7/24/2014
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 7/24/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
ArmaGen Technologies, Inc. Licenses AGT-182 Rights To Shire For Up To $225M 7/23/2014
AmorChem l.p. Invests In A Novel Drug For Atherosclerosis. 7/23/2014
Lion Biotechnologies, Inc. Leases New Research Laboratory 7/23/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
Assay Depot, Inc. Partners With Kansas City Area Life Science Institute To Create World’s First Academic Research Exchange 7/22/2014
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million 7/22/2014
SANUWAVE Health Signs Strategic Agreement With Premier Shockwave To Manage OssaTron Devices 7/22/2014
Galena Biopharma  (GALE) Enters Into Definitive Agreement to License U.S. Rights for Zuplenz® (ondansetron) Oral Soluble Film 7/22/2014